{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:21:18Z","timestamp":1786666878774,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-024-09563-9","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:12:40Z","timestamp":1734430360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["IGF2BP2 promotes lung adenocarcinoma progression by regulating LOX1 and tumor-associated neutrophils"],"prefix":"10.1007","volume":"73","author":[{"given":"Long","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"issue":"8","key":"9563_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356.","journal-title":"Nat Med"},{"issue":"6","key":"9563_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.21037\/atm-22-4479","volume":"11","author":"GO Ibodeng","year":"2023","unstructured":"Ibodeng GO, et al. A snapshot of lung cancer: where are we now?-a narrative review. Ann Transl Med. 2023;11(6):261.","journal-title":"Ann Transl Med"},{"issue":"5","key":"9563_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12025","volume":"40","author":"M Cao","year":"2020","unstructured":"Cao M, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40(5):205\u201310.","journal-title":"Cancer Commun (Lond)"},{"key":"9563_CR4","doi-asserted-by":"crossref","unstructured":"Zhou Y et al. Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma. npj Precision Oncology, 2023;7 1:121.","DOI":"10.1038\/s41698-023-00456-y"},{"issue":"6","key":"9563_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00408-020-00407-5","volume":"198","author":"M Alexander","year":"2020","unstructured":"Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer. Lung. 2020;198(6):897\u2013907.","journal-title":"Lung"},{"key":"9563_CR6","doi-asserted-by":"crossref","unstructured":"de Jong D. et al. Novel targets, novel treatments: the changing landscape of non-small cell lung cancer. Cancers (Basel). 2023;15 10.","DOI":"10.3390\/cancers15102855"},{"issue":"8","key":"9563_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. Jama. 2019;322(8):764\u201374.","journal-title":"Jama"},{"issue":"10","key":"9563_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.21037\/atm-22-4444","volume":"11","author":"MSC Li","year":"2023","unstructured":"Li MSC, Mok KKS, Mok TSK. Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. Ann Transl Med. 2023;11(10):358.","journal-title":"Ann Transl Med"},{"issue":"1","key":"9563_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/nar\/gky1012","volume":"47","author":"S M\u00fcller","year":"2019","unstructured":"M\u00fcller S, et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 2019;47(1):375\u201390.","journal-title":"Nucleic Acids Res"},{"key":"9563_CR10","doi-asserted-by":"crossref","unstructured":"Basheer AS, et al. Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications. Cancers (Basel). 2021;13 16.","DOI":"10.3390\/cancers13164226"},{"key":"9563_CR11","doi-asserted-by":"crossref","unstructured":"Zhong J, et al. Role of neutrophils on cancer cells and other immune cells in the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2023;1870 7:119493.","DOI":"10.1016\/j.bbamcr.2023.119493"},{"key":"9563_CR12","doi-asserted-by":"publisher","first-page":"1341390","DOI":"10.3389\/fimmu.2024.1341390","volume":"15","author":"I Di Ceglie","year":"2024","unstructured":"Di Ceglie I, et al. Immune cell networking in solid tumors: focus on macrophages and neutrophils. Front Immunol. 2024;15:1341390.","journal-title":"Front Immunol"},{"issue":"5","key":"9563_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-023-02552-z","volume":"130","author":"Y Ouyang","year":"2024","unstructured":"Ouyang Y, et al. Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial bladder carcinoma through the COX-2\/PGE2\/IDO1 Axis. Br J Cancer. 2024;130(5):880\u201391.","journal-title":"Br J Cancer"},{"issue":"11","key":"9563_CR14","doi-asserted-by":"publisher","first-page":"e2205613","DOI":"10.1002\/advs.202205613","volume":"10","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. ETV4 mediated tumor-associated neutrophil infiltration facilitates lymphangiogenesis and lymphatic metastasis of bladder cancer. Adv Sci (Weinh). 2023;10(11):e2205613.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"9563_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","volume":"38","author":"S Li","year":"2019","unstructured":"Li S, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res. 2019;38(1):6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"9563_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-024-12074-3","volume":"24","author":"JH Lee","year":"2024","unstructured":"Lee JH, Hong YM. The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma. BMC Cancer. 2024;24(1):327.","journal-title":"BMC Cancer"},{"issue":"1","key":"9563_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-022-01620-x","volume":"21","author":"H Lin","year":"2022","unstructured":"Lin H, et al. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol Cancer. 2022;21(1):148.","journal-title":"Mol Cancer"},{"issue":"1","key":"9563_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176.","journal-title":"Mol Cancer"},{"issue":"1","key":"9563_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, et al. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19(1):88.","journal-title":"Mol Cancer"},{"issue":"1","key":"9563_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-024-02092-2","volume":"10","author":"X Han","year":"2024","unstructured":"Han X, et al. Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming. Cell Death Discovery. 2024;10(1):331.","journal-title":"Cell Death Discovery"},{"issue":"9","key":"9563_CR21","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.18632\/aging.204679","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment. Aging (Albany NY). 2023;15(9):3857\u201389.","journal-title":"Aging (Albany NY)"},{"key":"9563_CR22","doi-asserted-by":"publisher","first-page":"114846","DOI":"10.1016\/j.biopha.2023.114846","volume":"163","author":"L Wang","year":"2023","unstructured":"Wang L, Tang Y. N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications. Biomed Pharmacotherapy. 2023;163:114846.","journal-title":"Biomed Pharmacotherapy"},{"issue":"23","key":"9563_CR23","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1177\/15353702231214266","volume":"248","author":"S Yang","year":"2023","unstructured":"Yang S, et al. Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma. Exp Biol Med (Maywood). 2023;248(23):2273\u201388.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"9563_CR24","doi-asserted-by":"publisher","first-page":"20684","DOI":"10.1038\/s41598-022-20730-6","volume":"12","author":"Q-C Zeng","year":"2022","unstructured":"Zeng Q-C, et al. Analysis of m6A modulator-mediated methylation modification patterns and the tumor microenvironment in lung adenocarcinoma. Scientific Reports. 2022;12(1):20684.","journal-title":"Scientific Reports"},{"issue":"2","key":"9563_CR25","doi-asserted-by":"publisher","first-page":"e0264384","DOI":"10.1371\/journal.pone.0264384","volume":"17","author":"W Ye","year":"2022","unstructured":"Ye W, Huang T. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma. PLoS One. 2022;17(2):e0264384.","journal-title":"PLoS One"},{"issue":"12","key":"9563_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40(12):1566-1582.e10.","journal-title":"Cancer Cell"},{"issue":"1","key":"9563_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18(1):112.","journal-title":"Mol Cancer"},{"issue":"2","key":"9563_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","volume":"11","author":"M Duan","year":"2024","unstructured":"Duan M, et al. IGF2BPs as novel m6A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment. Genes & Diseases. 2024;11(2):890\u2013920.","journal-title":"Genes & Diseases"},{"key":"9563_CR29","doi-asserted-by":"publisher","first-page":"153303382210853","DOI":"10.1177\/15330338221085373","volume":"21","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Four m6A RNA methylation gene signatures and their prognostic values in lung adenocarcinoma. Technol Cancer Res Treat. 2022;21:15330338221085372.","journal-title":"Technol Cancer Res Treat"},{"issue":"10","key":"9563_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41419-022-05316-4","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, et al. LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis. Cell Death Dis. 2022;13(10):877.","journal-title":"Cell Death Dis"},{"issue":"1","key":"9563_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, et al. m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023;22(1):99.","journal-title":"Mol Cancer"},{"key":"9563_CR32","doi-asserted-by":"crossref","unstructured":"Zhang L, et al. P1.21-05 the upregulated expression of IGF2BP2 predicts poor prognosis in lung adenocarcinoma and affects immune microenvironment and drug sensitivity. Journal of Thoracic Oncology, 2023;18 11:S235-S236.","DOI":"10.1016\/j.jtho.2023.09.391"},{"issue":"10","key":"9563_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41417-020-00279-0","volume":"28","author":"M Murdocca","year":"2021","unstructured":"Murdocca M, et al. LOX-1 and cancer: an indissoluble liaison. Cancer Gene Therapy. 2021;28(10):1088\u201398.","journal-title":"Cancer Gene Therapy"},{"issue":"6","key":"9563_CR34","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ijc.34134","volume":"151","author":"T Tsumita","year":"2022","unstructured":"Tsumita T, et al. The oxidized-LDL\/LOX-1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells. Int J Cancer. 2022;151(6):944\u201356.","journal-title":"Int J Cancer"},{"key":"9563_CR35","doi-asserted-by":"publisher","first-page":"106885","DOI":"10.1016\/j.vascn.2020.106885","volume":"104","author":"Y Huang","year":"2020","unstructured":"Huang Y, et al. Intrapulmonary inoculation of multicellular spheroids to construct an orthotopic lung cancer xenograft model that mimics four clinical stages of non-small cell lung cancer. J Pharmacol Toxicol Methods. 2020;104:106885.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"9563_CR36","doi-asserted-by":"publisher","first-page":"3494608","DOI":"10.1155\/2016\/3494608","volume":"2016","author":"M Orozco-Morales","year":"2016","unstructured":"Orozco-Morales M, et al. Interplay between cellular and molecular inflammatory mediators in lung cancer. Mediators Inflamm. 2016;2016:3494608.","journal-title":"Mediators Inflamm"},{"key":"9563_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-35723-8_1","volume":"1224","author":"L Wu","year":"2020","unstructured":"Wu L, Saxena S, Singh RK. Neutrophils in the tumor microenvironment. Adv Exp Med Biol. 2020;1224:1\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"9563_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lfs.2018.02.024","volume":"198","author":"S Balzan","year":"2018","unstructured":"Balzan S, Lubrano V. LOX-1 receptor: a potential link in atherosclerosis and cancer. Life Sci. 2018;198:79\u201386.","journal-title":"Life Sci"},{"issue":"6","key":"9563_CR39","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang C, et al. m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med. 2021;11(6):e426.","journal-title":"Clin Transl Med"},{"key":"9563_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.omtn.2021.04.003","volume":"24","author":"F Xu","year":"2021","unstructured":"Xu F, et al. m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD. Mol Ther Nucleic Acids. 2021;24:780\u201391.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"9563_CR41","doi-asserted-by":"publisher","first-page":"e2305142","DOI":"10.1002\/advs.202305142","volume":"11","author":"T Xia","year":"2024","unstructured":"Xia T, et al. IGF2BP2 drives cell cycle progression in triple-negative breast cancer by recruiting EIF4A1 to promote the m6A-modified CDK6 translation initiation process. Adv Sci (Weinh). 2024;11(1):e2305142.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"9563_CR42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","volume":"18","author":"C Hu","year":"2022","unstructured":"Hu C, et al. HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression. Int J Biol Sci. 2022;18(2):507\u201321.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"9563_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, et al. m6A methylated EphA2 and VEGFA through IGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13(5):483.","journal-title":"Cell Death Dis"},{"issue":"1","key":"9563_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41420-024-02133-w","volume":"10","author":"W Wu","year":"2024","unstructured":"Wu W, et al. METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma. Cell Death Discov. 2024;10(1):361.","journal-title":"Cell Death Discov"},{"issue":"1","key":"9563_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/0008-5472.CAN-20-1994","volume":"81","author":"CH Liu","year":"2021","unstructured":"Liu CH, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy. Cancer Res. 2021;81(1):144\u201357.","journal-title":"Cancer Res"},{"key":"9563_CR46","doi-asserted-by":"publisher","first-page":"688625","DOI":"10.3389\/fphar.2021.688625","volume":"12","author":"Z Tan","year":"2021","unstructured":"Tan Z, et al. The role of tumor inflammatory microenvironment in lung cancer. Front Pharmacol. 2021;12:688625.","journal-title":"Front Pharmacol"},{"issue":"1","key":"9563_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18(1):40.","journal-title":"Mol Cancer"},{"issue":"1","key":"9563_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/imr.12452","volume":"273","author":"M Ramadass","year":"2016","unstructured":"Ramadass M, Catz SD. Molecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammation. Immunol Rev. 2016;273(1):249\u201365.","journal-title":"Immunol Rev"},{"key":"9563_CR49","doi-asserted-by":"crossref","unstructured":"Korbecki J, et al. The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors-a review of literature. Int J Mol Sci. 2021;22 2.","DOI":"10.3390\/ijms22020843"},{"issue":"5","key":"9563_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/ol.2024.14322","volume":"27","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Prognostic value of tumor-associated CD177(+) neutrophils in lung adenocarcinoma. Oncol Lett. 2024;27(5):189.","journal-title":"Oncol Lett"},{"key":"9563_CR51","doi-asserted-by":"crossref","unstructured":"Kumar S, et al. Genome-wide scanning of potential hotspots for adenosine methylation: a potential path to neuronal development. Life (Basel) 2021;11 11.","DOI":"10.3390\/life11111185"},{"issue":"12","key":"9563_CR52","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1261\/rna.041178.113","volume":"19","author":"N Liu","year":"2013","unstructured":"Liu N, et al. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. Rna. 2013;19(12):1848\u201356.","journal-title":"Rna"},{"issue":"1","key":"9563_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-019-1105-0","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174.","journal-title":"Mol Cancer"},{"issue":"1","key":"9563_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13046-019-1470-y","volume":"38","author":"X Xu","year":"2019","unstructured":"Xu X, et al. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K\/Akt signaling pathway. J Exp Clin Cancer Res. 2019;38(1):497.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"9563_CR55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-021-01444-1","volume":"20","author":"J Li","year":"2021","unstructured":"Li J, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p\/KRAS and IGF2BP2\/Myc axes. Mol Cancer. 2021;20(1):138.","journal-title":"Mol Cancer"},{"issue":"10","key":"9563_CR56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-023-06163-7","volume":"14","author":"R Ji","year":"2023","unstructured":"Ji R, et al. IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression. Cell Death Dis. 2023;14(10):693.","journal-title":"Cell Death Dis"},{"issue":"10","key":"9563_CR57","doi-asserted-by":"publisher","first-page":"e23183","DOI":"10.1096\/fj.202202145RRR","volume":"37","author":"Y Shi","year":"2023","unstructured":"Shi Y, et al. IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m(6) A-dependent manner. Faseb j. 2023;37(10):e23183.","journal-title":"Faseb j"},{"key":"9563_CR58","doi-asserted-by":"publisher","first-page":"578816","DOI":"10.3389\/fonc.2020.578816","volume":"10","author":"J Pu","year":"2020","unstructured":"Pu J, et al. IGF2BP2 promotes liver cancer growth through an m6A-FEN1-dependent mechanism. Front Oncol. 2020;10:578816.","journal-title":"Front Oncol"},{"issue":"4","key":"9563_CR59","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41388-019-1015-z","volume":"39","author":"D Wang","year":"2020","unstructured":"Wang D, et al. C\/EBP\u03b4-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake. Oncogene. 2020;39(4):833\u201348.","journal-title":"Oncogene"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09563-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:02:30Z","timestamp":1770192150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09563-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9563"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09563-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal study and human ethical approval were given by the Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University (KY-2024-173-01, human study) and Laboratory Animal Center Ethics Committee of Soochow University (202306A0917, animal study).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"16"}}